Medical company Ark Therapeutics said a consortium led by University College London, in which the company was the sole industrial partner engaged in research, was to receive €6m from the EU. The grant would enable Ark's gene-therapy programme in foetal growth restriction to enter into clinical development, it said. Its shares rose 7.4% on the news.
Volex, a provider of electrical, digital and optical connections, said it had appointed David McKinney to the newly created position of Chief Operating Officer (COO). McKinney most recently served as COO of broadcast technology firm Pace from November 2005 to January 2012. The firm said it hoped the new hire would help drive "substantial, sustainable and profitable growth of the company".
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Will “Liberation Day” strike again?Donald Trump’s 90-day tariff pause comes to an end on 9 July. Can we expect further market turmoil?
-
Israel claims victory in the '12-day war' with IranDonald Trump may have announced a ceasefire in the 12-day war between Israel and Iran, but what comes next depends on what happens internally in Iran
